The TGA has approved certain psychedelic treatments: the response from experts is mixed
From July this year, some psychiatrists will be able to prescribe psychedelics to some patients. Responses from experts working in the field are mixed.
Primary Results
Two reasons I’m sceptical about psychedelic science
There are fundamental flaws in psychedelics research. But I’m still intrigued by their potential.
Do psychedelics really work to treat depression and PTSD? Here’s what the evidence says
In addition to placebo effects, patients might be motivated to report they have gotten better, even when they haven’t.
Psychedelics plus psychotherapy can trigger rapid changes in the brain − new research at the level of neurons is untangling how
Change in the brain usually comes with plenty of effort over time. Neuroscientists are working to understand how psychedelic drugs provide a shortcut that seems to rely on existing brain systems.
MDMA and psilocybin therapy rules have been relaxed. Here’s what might happen next
The psychiatrist used to have to stay with the patient during their entire session. Now they’ll be able to leave the room after administering the drug.
The rise of psychedelic capitalism: Work harder and be happy about it?
Psychedelics are marketed as a way for the general population to extract more work out of their already overworked lives, and to be happy about it in the process.
Psilocybin legislation is helping psychedelic drugs make a comeback – a drug researcher explains the challenges they face
Pharmaceutical giants like Johnson & Johnson as well as smaller startups are investing in psychedelic drug development, and both are pursuing FDA approval for their patented psilocybin formulations.
Two years on from Australia’s bold psychedelic experiment, here are our concerns
Psychedelic-assisted therapy offers promise. But new research highlights concerns about safety and accessibility.
Use of psychedelics to treat PTSD, OCD, depression and chronic pain – a researcher discusses recent trials, possible risks
The early research suggests the drugs might be effective for some conditions. But scientists have safety concerns.
Psychedelic medicine is on its way. But it’s not ‘doing shrooms with your shrink’. Here’s what you need to know
From July 1, authorised psychiatrists will be able to prescribe MDMA and psilocybin in some circumstances. Here’s what we’re excited and concerned about.